CRL-8256 is a selective compound that has shown promise as a potential therapeutic agent in the field of cancer treatment. It acts by targeting and inhibiting specific enzymes involved in cancer cell growth and survival, particularly those within the protein kinase family. By disrupting these critical pathways, CRL-8256 prevents the proliferation of tumor cells and induces apoptosis. This makes it a candidate for use in cancer therapies, particularly for tumors that are resistant to conventional treatments.
MedKoo Cat#: 146037
Name: CRL-8256
CAS#: 256424-07-4
Chemical Formula: C21H21N5O4
Exact Mass: 407.1600
Molecular Weight: 407.43
Elemental Analysis: C, 61.91; H, 5.20; N, 17.19; O, 15.71
The following data is based on the product molecular weight 407.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
